Director/PDMR Shareholding

RNS Number : 1314V

GlaxoSmithKline PLC

25 January 2017

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr B McNamara
b)	Position/status	CEO, Consumer Healthcare
c)	Initial notification/ amendment	Initial Notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	American Depositary Shares ('ADSs') ISIN: US37733W1053
b)	Nature of the transaction	The vesting of an award over 10,251 ADSs made under the GlaxoSmithKline Share Value Plan (SVP), granted to compensate for the value of awards forfeited on leaving Novartis, due to time pro-rating. Of the vested award, 3,926 ADSs were automatically withheld to meet tax liabilities.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			$38.72	10,251
d)	Aggregated information	n/a (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2017-01-23
f)	Place of the transaction	n/a

 

END

 

 

DSHQELFLDFFFBBE